Unit of Anaesthesia, Intensive Care and Pain Management, Department of Medicine, Campus Bio Medico University and Teaching Hospital, Rome, Italy.
Department of Anaesthesia, Intensive Care and Pain Management, Humanitas Mater Domini Hospital, Castellanza, Italy.
J Intern Med. 2020 Aug;288(2):192-206. doi: 10.1111/joim.13091. Epub 2020 May 13.
Severe acute respiratory syndrome coronavirus (SARS-CoV)-2, a novel coronavirus from the same family as SARS-CoV and Middle East respiratory syndrome coronavirus, has spread worldwide leading the World Health Organization to declare a pandemic. The disease caused by SARS-CoV-2, coronavirus disease 2019 (COVID-19), presents flu-like symptoms which can become serious in high-risk individuals. Here, we provide an overview of the known clinical features and treatment options for COVID-19. We carried out a systematic literature search using the main online databases (PubMed, Google Scholar, MEDLINE, UpToDate, Embase and Web of Science) with the following keywords: 'COVID-19', '2019-nCoV', 'coronavirus' and 'SARS-CoV-2'. We included publications from 1 January 2019 to 3 April 2020 which focused on clinical features and treatments. We found that infection is transmitted from human to human and through contact with contaminated environmental surfaces. Hand hygiene is fundamental to prevent contamination. Wearing personal protective equipment is recommended in specific environments. The main symptoms of COVID-19 are fever, cough, fatigue, slight dyspnoea, sore throat, headache, conjunctivitis and gastrointestinal issues. Real-time PCR is used as a diagnostic tool using nasal swab, tracheal aspirate or bronchoalveolar lavage samples. Computed tomography findings are important for both diagnosis and follow-up. To date, there is no evidence of any effective treatment for COVID-19. The main therapies being used to treat the disease are antiviral drugs, chloroquine/hydroxychloroquine and respiratory therapy. In conclusion, although many therapies have been proposed, quarantine is the only intervention that appears to be effective in decreasing the contagion rate. Specifically designed randomized clinical trials are needed to determine the most appropriate evidence-based treatment modality.
严重急性呼吸综合征冠状病毒(SARS-CoV-2)是一种新型冠状病毒,与严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒同属一家族,已在全球范围内传播,世界卫生组织宣布其为大流行。由 SARS-CoV-2 引起的疾病,即 2019 年冠状病毒病(COVID-19),表现出类似流感的症状,在高危人群中可能会变得严重。在这里,我们提供了 COVID-19 的已知临床特征和治疗选择的概述。我们使用主要在线数据库(PubMed、Google Scholar、MEDLINE、UpToDate、Embase 和 Web of Science)进行了系统的文献搜索,使用了以下关键字:'COVID-19'、'2019-nCoV'、'coronavirus' 和'SARS-CoV-2'。我们纳入了 2019 年 1 月 1 日至 2020 年 4 月 3 日发表的侧重于临床特征和治疗的出版物。我们发现感染是人与人之间通过接触受污染的环境表面传播的。手部卫生是防止污染的基础。建议在特定环境中佩戴个人防护设备。COVID-19 的主要症状是发热、咳嗽、疲劳、轻度呼吸困难、喉咙痛、头痛、结膜炎和胃肠道问题。实时 PCR 是使用鼻拭子、气管抽吸物或支气管肺泡灌洗液样本作为诊断工具。计算机断层扫描结果对诊断和随访都很重要。迄今为止,尚无任何有效治疗 COVID-19 的证据。目前用于治疗该疾病的主要疗法是抗病毒药物、氯喹/羟氯喹和呼吸疗法。总之,尽管提出了许多疗法,但隔离似乎是降低传染率的唯一有效干预措施。需要专门设计的随机临床试验来确定最合适的基于证据的治疗模式。